Clinic
Planned Parenthood Hudson Peconic INC.
Planned Parenthood Hudson Peconic INC. was paid $25.11M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 26% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD HUDSON PECONIC INC.
SMITHTOWN, NY 11787
SMITHTOWN, NY 11787
33aNPI1285701672assigned 11/29/2006
33bProvider typeAmbulatory Family Planning Facility
28Total paid$25.11M
24GClaims250,134
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Family Planning Facility providers in New York
Rank by total paid#2 of 7
Median peer was paid$9.13M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,122 | $1.73M | |
| 2019 | 26,516 | $1.90M | |
| 2020 | 50,688 | $5.17M | |
| 2021 | 40,079 | $4.76M | |
| 2022 | 35,588 | $4.44M | |
| 2023 | 34,948 | $4.11M | |
| 2024incomplete | 31,193 | $3.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 26% | 52,169 | 31,293 | $6.45M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 38,870 | 25,948 | $4.97M |
| 59840 | 8.8% | 3,012 | 3,000 | $2.21M | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 6.5% | 14,583 | 12,874 | $1.63M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 6.3% | 2,026 | 2,022 | $1.57M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.9% | 7,980 | 7,226 | $1.22M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.5% | 7,487 | 5,756 | $1.13M |
| J7300 | Intrauterine copper contraceptive (paragard) | 3.2% | 1,240 | 1,235 | $809K |
| 11976 | 2.5% | 1,061 | 1,058 | $619K | |
| S0190 | Mifepristone, oral, 200 mg | 2.0% | 8,036 | 8,003 | $506K |
| 11981 | 1.9% | 1,580 | 1,576 | $467K | |
| 58300 | 1.7% | 2,818 | 2,654 | $428K |
41 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.7% | 2,207 | $424K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1.7% | 8,145 | $424K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.7% | 3,687 | $418K |
| 99201 | 1.3% | 3,532 | $326K | |
| 58301 | 1.1% | 1,711 | $270K | |
| 86703 | <1% | 14,932 | $220K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,146 | $135K |
| 99051 | <1% | 11,128 | $134K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 240 | $132K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 608 | $115K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | <1% | 114 | $96K |
| 81025 | <1% | 29,406 | $91K | |
| 90651 | <1% | 444 | $83K | |
| 11982 | <1% | 251 | $78K | |
| 99385 | <1% | 292 | $64K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 180 | $38K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 7,877 | $13K |
| 99000 | <1% | 1,924 | $11K | |
| 57454 | <1% | 15 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,224 | $6K |
| 36416 | <1% | 337 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 67 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $3K |
| 76830 | Ultrasound, transvaginal | <1% | 30 | $2K |
| 85018 | <1% | 2,934 | $1K | |
| 87210 | <1% | 4,313 | $852.85 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 59 | $737.50 |
| 90674 | <1% | 34 | $592.88 | |
| 81002 | <1% | 1,635 | $483.74 | |
| 86850 | <1% | 12 | $473.23 | |
| 0031A | <1% | 24 | $453.23 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 903 | $262.02 |
| J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) | <1% | 13 | $134.05 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 26 | $85.72 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 392 | $85.69 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 117 | $44.77 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 54 | $13.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 54 | $13.00 |
| 81001 | 0% | 148 | $0.00 | |
| 91301 | 0% | 21 | $0.00 | |
| 91303 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTURIELLO, MICHAEL (FINANCE)